UBS raises Cullinan Oncology stock price target to $27 on trial data

UBS raises Cullinan Oncology stock price target to $27 on trial data
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.